Fundacion CRIS de Investigación para Vencer el Cáncer   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Madrid Spain (2010)

Organization Overview

First Clinical Trial
2018
NCT03448731
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fundacion CRIS de Investigación para Vencer el Cáncer